跳至主要内容
临床试验/TCTR20230711003
TCTR20230711003招募中不适用

The difference in gene expression in implantation-related genes between day 5 and day 6 euploid blastocysts

Ratchadapisek Sompoch Endowment Fund0 个研究点目标入组 20 人开始时间: 2023年7月11日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 42 Years(—)
性别
Female

入选标准

  • 1. Women diagnosed with infertility underwent treatment using IVF or ICSI with indication to test for preimplantation genetic testing for aneuploidy (PGT-A) to screen for genetic abnormalities before the embryos were transferred.
  • 2. The women received ovarian stimulation using the GnRH antagonist protocol, which involved the administration of recombinant gonadotropins for ovarian stimulation and the use of a GnRH antagonist to suppress premature ovulation. They also received human chorionic gonadotropin or a GnRH agonist to trigger ovulation.
  • 3. The women's age ranged from 18 to 42 years old.
  • 4. The embryos reached the blastocyst stage and underwent PGT-A, which confirmed that they had a normal chromosomal count (euploidy: 46XX or 46XY).

排除标准

  • 1. Women with abnormalities in the uterine cavity, such as endometrial polyps or myomas with endometrial invasion, may experience impaired fertility and affect the pregnancy rate.
  • 2. Women diagnosed with endometriosis or polycystic ovarian syndrome (PCOS).
  • 3. Body mass index (BMI) equal to or greater than 30 kg/m2

研究者

发起方
Ratchadapisek Sompoch Endowment Fund

相似试验